Back | Table of Contents | Abstract | PDF | Mail to Author |

Real-World Pathologic Complete Response Rates with Neoadjuvant Pembrolizumab in Stage II–III Triple-Negative Breast Cancer: Impact of Ki-67 Proliferation Index

Gokhan SAHIN¹, Oguzcan OZKAN¹, Caner ACAR¹, Haydar Cagatay YUKSEL¹, Sercan ON¹, Hasan Cagri YILDIRIM¹, Burcu CAKAR¹, Erhan GOKMEN¹

Ege University, Faculty of Medicine, Department of Medical Oncology

---

Back | Table of Contents | Abstract | PDF | Mail to Author |